Adherence therapy improves medication adherence and quality of life in people with Parkinson's disease: a randomised controlled trial

D J Daley; K H O Deane; R J Gray; A B Clark; M Pfeil; K Sabanathan; P F Worth; P K Myint

doi:10.1111/ijcp.12439

Adherence therapy improves medication adherence and quality of life in people with Parkinson's disease: a randomised controlled trial

D J Daley, K H O Deane, R J Gray, A B Clark, M Pfeil, K Sabanathan, P F Worth, P K Myint

Research output: Contribution to journal › Article › peer-review

Abstract

Many factors are associated with medication non-adherence in Parkinson's disease (PD), including complex treatment regimens, mood disorders and impaired cognition. However, interventions to improve adherence which acknowledge such factors are lacking. A phase II randomised controlled trial was conducted investigating whether Adherence Therapy (AT) improves medication adherence and quality of life (QoL) compared with routine care (RC) in PD.

Original language	English
Pages (from-to)	963-971
Number of pages	9
Journal	International Journal of Clinical Practice
Volume	68
Issue number	8
DOIs	https://doi.org/10.1111/ijcp.12439
Publication status	Published - Aug 2014

Access to Document

10.1111/ijcp.12439

Cite this

@article{17927d4d91704a2e8704c93f05ff481f,

title = "Adherence therapy improves medication adherence and quality of life in people with Parkinson's disease: a randomised controlled trial",

abstract = "Many factors are associated with medication non-adherence in Parkinson's disease (PD), including complex treatment regimens, mood disorders and impaired cognition. However, interventions to improve adherence which acknowledge such factors are lacking. A phase II randomised controlled trial was conducted investigating whether Adherence Therapy (AT) improves medication adherence and quality of life (QoL) compared with routine care (RC) in PD.",

author = "Daley, {D J} and Deane, {K H O} and Gray, {R J} and Clark, {A B} and M Pfeil and K Sabanathan and Worth, {P F} and Myint, {P K}",

note = "{\textcopyright} 2014 John Wiley & Sons Ltd.",

year = "2014",

month = aug,

doi = "10.1111/ijcp.12439",

language = "English",

volume = "68",

pages = "963--971",

journal = "International Journal of Clinical Practice",

issn = "1742-1241",

publisher = "Wiley",

number = "8",

}

TY - JOUR

T1 - Adherence therapy improves medication adherence and quality of life in people with Parkinson's disease: a randomised controlled trial

AU - Daley, D J

AU - Deane, K H O

AU - Gray, R J

AU - Clark, A B

AU - Pfeil, M

AU - Sabanathan, K

AU - Worth, P F

AU - Myint, P K

PY - 2014/8

Y1 - 2014/8

N2 - Many factors are associated with medication non-adherence in Parkinson's disease (PD), including complex treatment regimens, mood disorders and impaired cognition. However, interventions to improve adherence which acknowledge such factors are lacking. A phase II randomised controlled trial was conducted investigating whether Adherence Therapy (AT) improves medication adherence and quality of life (QoL) compared with routine care (RC) in PD.

AB - Many factors are associated with medication non-adherence in Parkinson's disease (PD), including complex treatment regimens, mood disorders and impaired cognition. However, interventions to improve adherence which acknowledge such factors are lacking. A phase II randomised controlled trial was conducted investigating whether Adherence Therapy (AT) improves medication adherence and quality of life (QoL) compared with routine care (RC) in PD.

U2 - 10.1111/ijcp.12439

DO - 10.1111/ijcp.12439

M3 - Article

C2 - 24750544

SN - 1742-1241

VL - 68

SP - 963

EP - 971

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

IS - 8

ER -